ClinicalTrials.Veeva

Menu

Preliminary Effectiveness of Remotely Monitored Blood Alcohol Concentration Device as Treatment Modality (Soberlink)

Yale University logo

Yale University

Status

Completed

Conditions

Alcohol Use Disorder

Treatments

Device: Soberlink

Study type

Interventional

Funder types

Other

Identifiers

NCT04380116
2000027787

Details and patient eligibility

About

State the scientific aim(s) of the study, or the hypotheses to be tested. The purpose of the current study is to evaluate the usage and acceptability of the Soberlink's blood alcohol concentration (BAC) unit in collaboration with Aware treatment to assess increased sobriety within patients suffering from alcohol use disorder (AUD).

The specific AIMS will be:

  1. To determine the effectiveness of Soberlink's ability to increase abstinence
  2. To evaluate the impact of Soberlink's device on the participant based on their quality of health and sobriety.
  3. To evaluate the extent to which need for higher levels of follow-up care and treatment is reduced for individuals who have had access to the Soberlink device.

Enrollment

96 patients

Sex

All

Ages

21 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • are at least 21 years old,
  • currently enrolled at Aware In home treatment,
  • Primary or secondary DSM-5 diagnosis of alcoholism use disorder (AUD).

Exclusion criteria

  • Current suicide or homicide risk,
  • meet criteria for DSM-IV current psychotic disorder, or bipolar disorder,
  • does not have phone access with text message capabilities
  • Unable to read or understand English,
  • Unable to complete the study because of anticipated incarceration or move,
  • Life-threatening or unstable medical problems,
  • No course of current or pending legal action,
  • Soberlink results being used for child custody or legal circumstance.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

96 participants in 2 patient groups

Sb+Aware
Experimental group
Description:
Patients will access to the Soberlink device and receive treatment with Aware Recovery Care
Treatment:
Device: Soberlink
Aware
No Intervention group
Description:
Patients will only have access to Aware Recovery Care

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems